Brief: Tevogen Values TVGN-489 at $9–$11B, Debuts First Clinical T Cell Therapy from ExacTcell™ Platform
08/09/2025 14:29
Sept 8 (Reuters) - Tevogen Bio Holdings Inc TVGN.O: TEVOGEN BIO HOLDINGS INC - VALUES TVGN-489 AT $9-$11 BILLION RISK-ADJUSTED NET PRESENT VALUE Source text: ID:nGNX7b7HNB Further company coverage: TVGN.O ((Reuters.Briefs@thomsonreuters.com;))